Trial Profile
Clinical, Pathologic Characteristics and Its Mechansim of Denosumab Treated Giant Cell Tumor of Bone
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 05 Nov 2021
Price :
$35
*
At a glance
- Drugs Denosumab (Primary)
- Indications Giant cell tumours
- Focus Therapeutic Use
- Acronyms D-Gct
- 28 Aug 2017 New trial record